National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

HARDBACK
price:$59.95
add to cart

Rights & Permissions

topleft topright

Dietary Supplements: A Framework for Evaluating Safety (2005)
Institute of Medicine (IOM)

Citation Manager

. "5 Categories of Scientific Evidence--Animal Data." Dietary Supplements: A Framework for Evaluating Safety. Washington, DC: The National Academies Press, 2005.

Please select a format:

BibTeX EndNote RefMan


Page
173
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Dietary Supplements: A Framework for Evaluating Safety
  • As a general guideline, human intakes that exceed one-one hundredth (0.01) of animal doses that produce Category A effects (see Table 5-1) should be considered to represent a significant risk to human health. Human intakes that exceed one-tenth (0.1) of the animal doses that produce Category B effects should be considered to represent a significant risk to human health.

REFERENCES

ASPCA (American Society for the Prevention of Cruelty to Animals). 2003. Animal Poison Control Center. Online. Available at http://www.napcc.aspca.org. Accessed July 8, 2003.


Capen CC, Dybing E, Rice JM, Wilbourn JD, eds. 1999. Species Differences in Thyroid, Kidney and Urinary Bladder Carcinogenesis. International Agency for Research on Cancer (IARC) Scientific Publication No. 147. Lyon, France: IARC.

CDER (Center for Drug Evaluation and Research). 2002. Guidance Documents. Online. Food and Drug Administration. Available at http://www.fda.gov/cder/guidance/index.htm. Accessed May 2, 2002.

Cheeke PR. 1998. Natural Toxicants in Feeds, Forages, and Poisonous Plants. 2nd ed. Danville, IL: Interstate Publishers.

Colegate SM, Dorling PR, eds. 1994. Plant-Associated Toxins: Agricultural, Phytochemical and Ecological Aspects. Wallingford, UK: CAB International.

Cornell University. 2002. Poisonous Plants Informational Database. Online. Available at http://www.ansci.cornell.edu/plants/index.html. Accessed July 8, 2003.


Dourson ML, Stara JF. 1983. Regulatory history and experimental support of uncertainty (safety) factors. Regul Toxicol Pharmacol 3:224–238.

Dourson ML, Felter SP, Robinson D. 1996. Evolution of science-based uncertainty factors in noncancer risk assessment. Regul Toxicol Pharmacol 24:108–120.


Everist SL. 1981. Poisonous Plants of Australia. London: Angus & Robertson Publishers.


Garland T, Barr AC, eds. 1998. Toxic Plants and Other Natural Toxicants. Wallingford, UK: CAB International.


Hayes W. 2001. Principles and Methods of Toxicology. 4th ed. Philadelphia: Taylor and Francis.

Huff J. 1999. Long-term chemical carcinogenesis bioassays predict human cancer hazards. Issues, controversies, and uncertainties. Ann NY Acad Sci 895:56–79.


IARC (International Agency for Research on Cancer). 1999. Cyclamates. IARC Monogr Eval Carcinog Risks Hum 73:195–222.

ICH/FDA (International Conference on Harmonisation/Food and Drug Administration). 2001. Guidance for Industry: S7A Safety Pharmacology Studies for Human Pharmaceuticals. Rockville, MD: FDA.


James LF, Keeler RF, Cheeke PR, Bailey EM Jr, Hegarty MP, eds. 1992. Poisonous Plants. Ames, IA: Iowa State University Press.


Keeler RF, Tu AT, eds. 1983. Handbook of Natural Toxins. Volume 1. Plant and Fungal Toxins. New York: Marcel Dekker.

Keeler RF, Tu AT. 1991. Handbook of Natural Toxins, Volume 6. Toxicology of Plant and Fungal Compounds. New York: Marcel Dekker.

Keeler RF, Van Kampen KR, James LF, eds. 1978. Effects of Poisonous Plants on Livestock. New York: Academic Press.

Kellerman TS, Coetzer JAW, Naudé TW. 1988. Plant Poisonings and Mycotoxicoses of Livestock in Southern Africa. Cape Town, South Africa: Oxford University Press.

Page
173
Front Matter (R1-R20)
Executive Summary (1-18)
1 Introduction and Background (19-42)
2 Approaches Used by Others and Existing Safety Frameworks (43-84)
3 The Framework (85-125)
4 Categories of Scientific Evidence--Human Information and Data (126-155)
5 Categories of Scientific Evidence--Animal Data (156-174)
6 Categories of Scientific Evidence--Information About Related Substances (175-216)
7 Categories of Scientific Evidence--In Vitro Data (217-234)
8 Interactions (235-246)
9 Vulnerable Groups and Prevalance of Use (247-252)
10 Scientific Principles for Integrating and Evaluating the Available Data (253-268)
11 Applying the Framework: Case Studies Using the Prototype Safety Monographs (269-291)
12 Factors Influencing Use of the Safety Framework (292-296)
13 Findings and Recommendations (297-306)
Appendix A: Existing Frameworks or Systems for Evaluating the Safety of Other Substances (307-315)
Appendix B: Scope of Work and Comments to Initial July 2002 Framework (316-321)
Appendix C: Plant Family Information (322-355)
Appendix D: Chaparral: Prototype Monograph Summary (356-362)
Appendix E: Glucosamine: Prototype Monograph Summary (363-366)
Appendix F: Melatonin: Prototype Monograph Summary (367-371)
Appendix G: Chromium Picolinate: Prototype Monograph Summary (372-375)
Appendix H: Saw Palmetto: Prototype Monograph Summary (376-379)
Appendix I: Shark Cartilage: Prototype Monograph Summary (380-384)
Appendix J: Prototype Focused Monograph: Review of Liver-Related Risks for Chaparral (385-449)
Appendix K: Protoype Focused Monograph: Review of Anti-Androgenic Risks of Saw Palmetto Ingestion by Women (450-477)
Appendix L: Acknowledgements (478-480)
Appendix M: Biographical Sketches of Commitee Members (481-488)
Index (489-506)